Peptide inhibiting murine double minute 2 (MDM2) and murine double minute X (MDMX)

Peptide inhibiting murine double minute 2 (MDM2) and murine double minute X (MDMX)
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2017-04-19 00:00:00
Sponsor Aileron Therapeutics, Inc.;81 Albany Street;Cambridge, Massachusetts, 02139
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia